Authors
Loading...
Preclinical study demonstrates that lactate-driven YY1 lactylation disrupts epithelial barriers in acute lung injury, highlighting a therapeutic target for ARDS.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: